Oncological outcomes after complete mesocolic excision in right-sided colon cancer: a population-based study.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
06 2021
Historique:
revised: 06 02 2021
received: 24 11 2020
accepted: 17 02 2021
pubmed: 25 2 2021
medline: 4 9 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

Complete mesocolic excision (CME) has been proposed as the preferred surgical technique for resection of colon cancer. This prospective cohort study evaluates the effect of CME surgery on colon cancer mortality after right-sided hemicolectomy on a population level. Data from the Swedish Colorectal Cancer Registry and the Cause of Death Registry on all patients treated with elective right-sided hemicolectomy for colon cancer Stages I-III in the Stockholm County 2008-2012 were analysed. Adherence to principles of CME surgery was determined by structured analysis of anonymized surgical reports regarding the presence of five essential features. The exposure to CME was graded as group 0 (not exposed to CME), group 1 (intermediate) and group 2 (exposed to CME). In total, 1171 patients were analysed with 234 (20.0%) patients in CME group 0, 453 (38.7%) patients in CME group 1 and 484 (41.3%) in CME group 2. The 5-year colon cancer mortality was 20.2% in CME group 0, 13.9% in CME group 1 and 13.1% in CME group 2 (P = 0.026). The adjusted hazard ratio for colon cancer mortality was 0.61 (95% CI 0.42-0.91; P = 0.014) for CME group 1 and 0.52 (95% CI 0.35-0.77; P = 0.001) for CME group 2. The presence of predefined CME features in surgical reports was related to a graded benefit on cancer-specific mortality after right-sided hemicolectomy for colon cancer Stages I-III.

Identifiants

pubmed: 33624416
doi: 10.1111/codi.15601
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1404-1413

Subventions

Organisme : Stockholms Läns Landsting
Organisme : Medtronic

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Association of Coloproctology of Great Britain and Ireland.

Références

Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum. 2003;46(7):860-6.
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome. Colorectal Dis. 2009;11(4):354-64.
West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28(2):272-8.
Bernhoff R, Holm T, Sjovall A, Granath F, Ekbom A, Martling A. Increased lymph node harvest in patients operated on for right-sided colon cancer: a population-based study. Colorectal Dis. 2012;14(6):691-6.
Bertelsen CA, Neuenschwander AU, Jansen JE, Wilhelmsen M, Kirkegaard-Klitbo A, Tenma JR, et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015;16(2):161-8.
Bernhoff R, Martling A, Sjovall A, Granath F, Hohenberger W, Holm T. Improved survival after an educational project on colon cancer management in the county of Stockholm-a population based cohort study. Eur J Surg Oncol. 2015;41(11):1479-84.
Merkel S, Weber K, Matzel KE, Agaimy A, Gohl J, Hohenberger W. Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision. Br J Surg. 2016;103(9):1220-9.
Killeen S, Mannion M, Devaney A, Winter DC. Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review. Colorectal Dis. 2014;16(8):577-94.
Bertelsen CA, Neuenschwander AU, Jansen JE, Kirkegaard-Klitbo A, Tenma JR, Wilhelmsen M, et al. Short-term outcomes after complete mesocolic excision compared with ‘conventional’ colonic cancer surgery. Br J Surg. 2016;103(5):581-9.
Bernhoff R, Sjovall A, Buchli C, Granath F, Hol T, Martling A. Complete mesocolic excision (CME) in right sided colon cancer does not increase severe short term postoperative adverse events. Colorectal Dis. 2017;20(5):383-389.
West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9(9):857-65.
Bokey L, Chapuis PH, Chan C, Stewart P, Rickard MJ, Keshava A, et al. Long-term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision. Colorectal Dis. 2016;18(7):676-83.
Kanemitsu Y, Komori K, Kimura K, Kato T. D3 lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer. Dis Colon Rectum. 2013;56(7):815-24.

Auteurs

Richard Bernhoff (R)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Surgery, Capio St Göran Hospital, Stockholm, Sweden.

Annika Sjövall (A)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden.

Fredrik Granath (F)

Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Torbjörn Holm (T)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Department of Surgery, Södersjukhuset, Stockholm, Sweden.

Anna Martling (A)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden.

Christian Buchli (C)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH